Conceptio › Archive › HAL (France)
HAL (France)open access

Durvalumab after radiotherapy in patients with unresectable stage III non-small-cell lung cancer ineligible for chemotherapy: the DUART phase II nonrandomized controlled study

A.R. Filippi et al.
HAL (France) · Papers · License: Open Access
Open Source ↗
non-small-cell-lung-cancerradiotherapy
0, Durvalumab, Frail, Unresectable, Non-small-cell lung cancer, 1, Radiotherapy
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 257451
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.